The global hydroxychloroquine and chloroquine market is forecast to witness substantial growth over the coming years. This growth is primarily driven by increasing cases of COVID-19 pandemic globally, no specific treatment available for COVID-19 patients, a rising number of worldwide deaths as well as increasing cases of malaria and another autoimmune disease such as lupus erythematosus and rheumatoid arthritis globally. Hydroxychloroquine has created a revolutionary impact globally for the treatment of COVID-19 during in-vivo studies and laboratory testing. Hydroxychloroquine and Chloroquine is a pharmaceutical drug that is primarily used for the stoppage and treatment of various forms of malaria such as chloroquine-sensitive malaria, rheumatoid arthritis, and others. Apart from malaria, the drug is also used for the treatment of lupus erythematosus, rheumatoid arthritis, and Q fever.
According to 6Wresearch, Global Hydroxychloroquine And Chloroquine Market is projected to grow substantially during 2020-2026. This growth is primarily driven by the increasing import of hydroxychloroquine and chloroquine by major developed countries, for instance, the U.S. and other key European countries such as Spain, Italy, France, and Germany for the treatment of COVID-19. The demand for hydroxychloroquine has skyrocket globally ever since the U.S. government has imported huge quantities of hydroxychloroquine from India. Additionally, several countries such as Brazil, Canada, Bahrain, Seychelles, Mauritius, and the SAARC neighboring countries have also exported hydroxychloroquine from India.
In terms of dosage, 400 mg dosage vertical accounted for the majority of the market share in the global hydroxychloroquine and chloroquine market. In terms of regions, India is one of the leading producers of hydroxychloroquine and chloroquine globally and several Indian players have increased the production volumes of hydroxychloroquine in order to meet the internal and export demand. Whereas, in terms of type, the tablet form of hydroxychloroquine and chloroquine is dominating the global hydroxychloroquine and chloroquine market.
Some of the key players in the global hydroxychloroquine and chloroquine market are Teva, Torrent Pharma, Mylan, Novartis, Cadila healthcare, BSE healthcare, Shenhua Pharm, Sanofi, H-QYN, TAJ Pharma, Sandoz, HIKMA, IPCA, Shanghai Pharma, MAAN Medex, Cinkate, and Concordia Healthcare.
Key Highlights of the Report:
- Global Hydroxychloroquine and Chloroquine Market Overview
- Porter’s Five Force Analysis and Market Opportunity Assessment
- Global Hydroxychloroquine and Chloroquine Market Shares, By players
- Global Hydroxychloroquine and Chloroquine Market Trends
- Global Hydroxychloroquine and Chloroquine Market Outlook
- Global Hydroxychloroquine and Chloroquine Market Forecast
- Market Drivers & Restraints
- Company Profiles
- Key Strategic Recommendations
Check Other Related Market Research Report: Global Mycotoxin Testing Market
For Further details, please contact:
- Email Us: [email protected]
- Call Now: +91-11-430-24-305
